Gene · 4205
Papers4,395
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 4,395
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TAMC: A deep-learning approach to predict motif-centric transcriptional factor binding activity based on ATAC-seq profile. | PLoS Comput Biol | 2022 | 36094959 | PubTator, text mining | PubMed |
| m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of coronary heart disease. | Front Cardiovasc Med | 2022 | 36093132 | PubTator, text mining | PubMed |
| Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology. | Mol Ther Methods Clin Dev | 2022 | 36092361 | PubTator, text mining | PubMed |
| Activation of the NFκB signaling pathway in IL6+CSF3+ vascular endothelial cells promotes the formation of keloids. | Front Bioeng Biotechnol | 2022 | 36082167 | PubTator, text mining | PubMed |
| Histone Deacetylases Function in the Control of Early Hematopoiesis and Erythropoiesis. | Int J Mol Sci | 2022 | 36077192 | PubTator, text mining | PubMed |
| Targeting firing rate neuronal homeostasis can prevent seizures. | Dis Model Mech | 2022 | 36073607 | PubTator, text mining | PubMed |
| Roles of calcium signaling in cancer metastasis to bone. | Explor Target Antitumor Ther | 2022 | 36071984 | PubTator, text mining | PubMed |
| Identifying enhancer properties associated with genetic risk for complex traits using regulome-wide association studies. | PLoS Comput Biol | 2022 | 36070311 | PubTator, text mining | PubMed |
| MIRA: joint regulatory modeling of multimodal expression and chromatin accessibility in single cells. | Nat Methods | 2022 | 36068320 | PubTator, text mining | PubMed |
| Recent advances in molecular biology of metabolic syndrome pathophysiology: endothelial dysfunction as a potential therapeutic target. | J Diabetes Metab Disord | 2022 | 36065330 | PubTator, text mining | PubMed |
| Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis. | Heliyon | 2022 | 36061031 | PubTator, text mining | PubMed |
| The therapeutic potential of Houttuynia cordata: A current review. | Heliyon | 2022 | 36061012 | PubTator, text mining | PubMed |
| Pathogenesis, therapeutic strategies and biomarker development based on "omics" analysis related to microglia in Alzheimer's disease. | J Neuroinflammation | 2022 | 36058959 | PubTator, text mining | PubMed |
| Harnessing conserved signaling and metabolic pathways to enhance the maturation of functional engineered tissues. | NPJ Regen Med | 2022 | 36057642 | PubTator, text mining | PubMed |
| Characterizing the secretome of licensed hiPSC-derived MSCs. | Stem Cell Res Ther | 2022 | 36056373 | PubTator, text mining | PubMed |
| Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress. | J Headache Pain | 2022 | 36050647 | PubTator, text mining | PubMed |
| 14-weeks combined exercise epigenetically modulated 118 genes of menopausal women with prediabetes. | Front Endocrinol (Lausanne) | 2022 | 36046788 | PubTator, text mining | PubMed |
| The complex genetic basis of fibromuscular dysplasia, a systemic arteriopathy associated with multiple forms of cardiovascular disease. | Clin Sci (Lond) | 2022 | 36043395 | PubTator, text mining | PubMed |
| Compendium of proteins containing segments that exhibit zero-tolerance to amino acid variation in humans. | Protein Sci | 2022 | 36040257 | PubTator, text mining | PubMed |
| An Overview of the Advances in Research on the Molecular Function and Specific Role of Circular RNA in Cardiovascular Diseases. | Biomed Res Int | 2022 | 36033554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4205/papers?page=34